Gene · 2355
FOSL2: FOS like 2, AP-1 transcription factor subunit
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FOSL2: FOS like 2, AP-1 transcription factor subunit. Genes, record 2355. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2355
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P15408 | Fos-related antigen 2 | 326 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents54
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46622 | P15408 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14972 | P15408 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28548 | P15408 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14972 | P15408 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 14972 | P15408 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 28548 | P15408 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14811 | P15408 | Espacenet |
| JP 2024519218 A | 2024-05-09 | 117 | P15408 | Espacenet |
| KR 1020240005837 A | 2024-01-12 | 74 | P15408 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 28548 | P15408 | Espacenet |
1 to 10 of 54
See all 54 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,429
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FOSL2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30AG017265 | USC/UCLA Center on Biodemography and Population Health | 12 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 6 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 5 | 2025 |
| ZIABC010309 | Nuclear Architecture and Disease | 5 | 2025 |
| ZIAES103311 | Environmental Signaling in Reproduction and Pregnancy | 5 | 2025 |
1 to 10 of 2,429Source NIH's project files
See all 2,429 nih grantsPapers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional circuits of the glioma microenvironment: FOSL2 as a master regulator of the pathological niche. | Genes Dis | 2027 | 42698676 | PubTator, text mining | PubMed |
| The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathway. | Mol Biomed | 2026 | 42776394 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies macrophage immunometabolic signatures in ulcerative colitis. | Front Cell Infect Microbiol | 2026 | 42755516 | PubTator, text mining | PubMed |
| Preliminary analysis of chromatin accessibility in osteosarcoma tissues. | Clinics (Sao Paulo) | 2026 | 42700546 | PubTator, text mining | PubMed |
| Integrated Toxicogenomic Analysis Reveals Potential Molecular Signatures Associated with Cadmium-Related Osteoarthritis. | Biol Trace Elem Res | 2026 | 42698020 | PubTator, text mining | PubMed |
| Interleukin13 Ameliorates Hepatocellular Steatosis via IL13Rα1/JNK/FOSL2 Signaling Pathway. | Cell Mol Gastroenterol Hepatol | 2026 | 42692359 | PubTator, text mining | PubMed |
| Driver genomic lesions in MDM2, CDK4, and JUN co-opt targetable super-enhancer networks to impose liposarcomagenic core regulatory circuitry. | J Adv Res | 2026 | 42674282 | PubTator, text mining | PubMed |
| Hypoxia-Driven Mechanisms in Ischemic Heart Failure: A Bioinformatics, Machine Learning and Bayesian Network Study. | Cardiovasc Toxicol | 2026 | 42645701 | PubTator, text mining | PubMed |
| Multi-omics integration identifies VIM and LGALS3 as apoptosis-associated genes in astrocytes after traumatic brain injury. | Neuroscience | 2026 | 42617790 | PubTator, text mining | PubMed |
| PhiKan 083 Inhibits MYCN Expression in Liver Cancer Cells Independent of p53 Pathways. | ACS Pharmacol Transl Sci | 2026 | 42614793 | PubTator, text mining | PubMed |
1 to 10 of 2,749
See all 2,749 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2355
GET https://conductscience.org/api/genes/v1/2355/patents?page=2